Last update - 00:00 03/10/2006
Perrigo gets FDA nod for nail fungus lacquer
Ciclopirox, the generic version of Sanofi Aventis' Penlac tentatively approved
By AP
Health care products maker Perrigo Co. said Monday the Food and Drug Administration tentatively approved its version of a nail lacquer made by a division of Sanofi Aventis.
Final approval of the product, called Ciclopirox Topical Solution 8 percent, is subject to the expiration of the patent on Sept. 18, 2007. Sanofi's Dermik Laboratories makes the patent-protected product, called Penlac Nail Lacquer.
The nail lacquer treats mild to moderate fungal infections of fingernails and toenails and had sales of $125 million for the 12 months ending in August, according to industry data cited by Perrigo.
Shares of Perrigo, which is dual listed in New York and Tel Aviv, fell 9 cents to close at $16.88 on the Nasdaq last night.